Involvement of nitric oxide production in the mildronate mechanism of action

Pharmacology Reviews and Communications

Volumn 12, Issue 3, 2002, Pages 163-170

  Dzintare, Maija ^a   Baumane, Larisa ^a   Meirena, Dainuvite ^a   Lauberte, Lasma ^a   Kalvinsh, Ivars ^a   Sjakste, Nikolajs ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

Author keywords

EPR; Gamma butyrobetaine; Mildronate; Nitric oxide

Indexed keywords

ESTERASE; GAMMA BUTYROBETAINE; MILDRONATE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ELECTRON SPIN RESONANCE; ENZYME ACTIVATION; HEART; HYPOTHESIS; INHIBITION KINETICS; KIDNEY PARENCHYMA; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYNTHESIS;

EID: 0036629680     PISSN: 10288945     EISSN: None     Source Type: Journal    
DOI: 10.1080/10604450213832     Document Type: Article

References (12)

1. Blium Ia.B., Kalvin'sh I.Ia., Kucherenko N.E. and Lukevits E.Ia. (1987) Effect of quaterin and S-methylmethionine on the intensity of chromatin protein methylation. Woenno-Meditsinskiy Journal, 59, 18-24.
2. Blium Ia.B., Kalvin'sh I.Ia., Kucherenko N.E. and Lukevits E.Ia. (1988) Stimulation with quaterin of DNA replication and repair. Woenno-Meditsinskiy Journal, 60, 19-23.
3. 2+ uptake activity in rats with congestive heart failure following myocardial infarction. Molecular and Cellular Biochemistry, 209, 39-46.
4. Heidemanis K., Balcere I. and Kalvinsh I. (1990) Mildronate-plasma membrane interaction mechanisms. Proceedings of the Latvian Academy of Sciences, 11, 108-115.
5. Hosein E. A., Kato A., Vine E. and Hill A.M. (1970) Identification of acetyl-carnitoylcholine in rat brain extracts and the comparison of its cholinomimetic properties with acetylcholine. Canadian Journal of Physiology and Pharmacology, 48, 709-722.
6. 6 A61K 31/205, 12.01.1999.
7. Shen J., Wang J., Zhao B., Hou J., Gan T. and Xin W. (1998) Effects of Egb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo. Biochim. Biophys. Acta, 1406, 228-236.
8. Shutenko Zh.V., Meirena D.V., Kagan T.I. and Sjakste N.I. (1995) Mildronate: mechanisms of action, perspective for pathology correction. Khimiko-Pharmatsevticheskiy Zhurnal, 29, 13-17. (In Russian).
9. Simkhovich B., Shutenko Zh., Meirena D., Khagi K.B., Mežapuke R.J., Molodchina T.N., Kalvinš I.J. and Lukevics E. (1988) 3-(2,2,2,-trimethylhydrazinium) propionate (THP)-a novel γ-butyrobetaine hydroxylase inhibitor with cardioprotective properties. Biochemical Pharmacology, 37, 195-202.
10. Sjakste N., Baumane L., Meirena D., Lauberte L., Dzintare M. and Kalvinsh I. (1999) Drastic increase in nitric oxide content in rat brain under halothane anaesthesia, revealed by EPR method. Biochemical Pharmacology, 58, 1955-1959.
11. Sjakste N., Meirena D., Dzene A., Mezhapuke R., Ignatovich L. and Lukevics E. (1992) Modifications of the genome expression by several novel drugs. Experimental Biology (Vilnius), 3-4, 26.
12. Vanin A.F., Mordvintsev P.I. and Kleschev A.L. (1984) Appearance of nitric oxide in animal tissues in vivo. Studia Biophysica, 102, 135-142.